This paper is in the following e-collection/theme issue:

Systematic Review Protocols (244)

Published on in Vol 8, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12045, first published .
The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review

The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review

The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review

Authors of this article:

Mahsa Ghajarzadeh1 Author Orcid Image ;   Abbas Ali Keshtkar2 Author Orcid Image ;   Amirreza Azimi3 Author Orcid Image ;   Mohammad Ali Sahraian3 Author Orcid Image ;   Mehdi Mohammadifar4 Author Orcid Image ;   Sreeram V Ramagopalan5 Author Orcid Image
Article Authors Cited by (8) Tweetations (5) Metrics

Journals

  1. Ghajarzadeh M, Azimi A, Valizadeh Z, Sahraian M, Mohammadifar M. Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis. Autoimmunity Reviews 2020;19(8):102585 View
  2. Ghajarzadeh M, Mohammadi A, Sahraian M. Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis. Autoimmunity Reviews 2020;19(10):102650 View
  3. Mirmosayyeb O, Barzegar M, Nehzat N, Shaygannejad V, Sahraian M, Ghajarzadeh M. The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis. Journal of Clinical Neuroscience 2020;79:33 View
  4. Azimi A, Hanaei S, Sahraian M, Mohammadifar M, Ramagopalan S, Ghajarzadeh M. Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis. BMC Neurology 2019;19(1) View
  5. Hanaei S, Sahraian M, Mohammadifar M, Ramagopalan S, Ghajarzadeh M. Effect of Vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): A systematic review and meta-analysis. International Journal of Preventive Medicine 2021;12(1):42 View
  6. Mirmosayyeb O, Shaygannejad V, Ebrahimi N, Ghoshouni H, Ghajarzadeh M. The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis. Neurología (English Edition) 2022 View
  7. Azadvari M, Mirmosayyeb O, Hosseini M, Vaheb S, Razavi S. The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurological Sciences 2022;43(6):3879 View
  8. Shahraki Z, Rastkar M, Rastkar E, Mohammadifar M, Mohamadi A, Ghajarzadeh M. Impact of menopause on relapse rate and disability level in patients with multiple sclerosis (MS): a systematic review and meta-analysis. BMC Neurology 2023;23(1) View